A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: BI 1015550 mixed with [C-14]-BI 1015550
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 8
- Registration Number
- NCT05707403
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
Safety of Nintedanib in Real World in China
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT05676112
A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device
Not Applicable
Completed
- Conditions
- Pulmonary Fibrosis
- Interventions
- Device: A wearable cough monitoring device, the Strados Labs RESPᵀᴹ sensor, with an accompanying mobile application (App) for data collection
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 53
- Registration Number
- NCT05670587
- Locations
- 🇧🇪
Kortrijk - HOSP AZ Groeninge Kennedylaan, Kortrijk, Belgium
🇺🇸Critical Care, Pulmonary and Sleep Associates, Lakewood, Colorado, United States
🇺🇸Southeastern Research Center, Winston-Salem, North Carolina, United States
PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 52
- Registration Number
- NCT05670821
- Locations
- 🇯🇵
Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 28
- Registration Number
- NCT05661344
- Locations
- 🇩🇪
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 64
- Registration Number
- NCT05658107
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT05633862
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)
- Conditions
- Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT05624281
A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- Drug: [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)Drug: [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 2)
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 13
- Registration Number
- NCT05613036
- Locations
- 🇭🇺
PRA Hungary Ltd., Budapest, Hungary
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 19
- Registration Number
- NCT05613777
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
© Copyright 2025. All Rights Reserved by MedPath